PERIMETER SOLUTIONS, INC. (PRM) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 2.28%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 2.28% | Share-based compensation / revenue. Period ending 2026-06-30. $17.23M ÷ $757.07M × 100 ≈ 2.28% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 757.07M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 17.23M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -383.04M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $757.07M | $17.23M | $-383.04M | (m) | (m) | 2.28% | (m) | (m) |
| 2026-03-31 | (m) | $705.90M | $16.57M | $-206.25M | (m) | (m) | 2.35% | (m) | (m) |
| 2025-12-31 | (m) | $652.86M | $16.65M | $-200.93M | (m) | (m) | 2.55% | (m) | (m) |
| 2025-09-30 | (m) | $636.34M | $16.23M | $25.55M | (m) | (m) | 2.55% | (m) | (m) |
| 2025-06-30 | (m) | $609.32M | $13.02M | $77.66M | (m) | (m) | 2.14% | (m) | (m) |
| 2025-03-31 | (m) | $573.95M | $13.78M | $148.90M | (m) | (m) | 2.40% | (m) | (m) |
| 2024-12-31 | (m) | $560.97M | $12.85M | $-3.77M | (m) | (m) | 2.29% | (m) | (m) |
| 2024-09-30 | (m) | $534.19M | $9.77M | $-74.00M | (m) | (m) | 1.83% | (m) | (m) |
| 2024-06-30 | (m) | $388.43M | $8.21M | $-11.60M | (m) | (m) | 2.11% | (m) | (m) |
| 2024-03-31 | (m) | $337.29M | $6.41M | $6.73M | $41.88M | (m) | 1.90% | 0.16× | Reported |
| 2023-12-31 | (m) | $322.11M | $1.60M | $94.45M | $41.38M | (m) | 0.50% | 2.28× | Reported |
| 2023-09-30 | (m) | $303.93M | $6.97M | $43.61M | $40.94M | (m) | 2.29% | 1.07× | Reported |
| 2023-06-30 | (m) | $321.78M | $4.37M | $147.57M | $40.44M | (m) | 1.36% | 3.65× | Reported |
| 2023-03-31 | (m) | $346.61M | $6.61M | $99.86M | $42.23M | (m) | 1.91% | 2.36× | Reported |
| 2022-12-31 | (m) | $360.50M | $14.65M | $130.06M | $42.59M | (m) | 4.06% | 3.05× | Reported |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-11-08 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $339.58M | $0.00 | $71.48M | $42.02M | (m) | 0.00% | 1.70× | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $239.31M | $0.00 | $-5.78M | $51.66M | (m) | 0.00% | -0.11× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BALCHEM CORP (BCPC) | United States | $5.347B | 32.84 |
| Ingevity Corp (NGVT) | United States | $2.468B | 47.72 |
| INNOSPEC INC. (IOSP) | United States | $2.380B | 16.37 |
| Chemours Co (CC) | United States | $2.136B | -10.64 |
| OLIN Corp (OLN) | United States | $1.852B | -11.54 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| Solstice Advanced Materials Inc. (SOLS) | United States | $8.905B | 67.02 |
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |